	Pathogenesis of cutaneous T-cell lymphoma: Malignant inflammation, immune reprogramming, and microenvironmental drivers. J Invest Dermatol Calvão J, Iselin C, Wasmayr J, Furtmüller C, Zeng Z, Vadivel CK, Gluud M, Bataiosu-Zimmer E, Buus TB, Ødum N, Gonçalo M, Guenova E. PMID: 42274451 [PubMed - as supplied by publisher]
	Frailty in Children and Adolescents With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Receiving Maintenance Chemotherapy-A Pilot Study. J Pediatr Hematol Oncol Cochran TR, Fulbright J, Butrous S, Lee B, August K, Jayaraman S, White DA. PMID: 42274383 [PubMed - as supplied by publisher]
	A Prospective Study Comparing Treatment Outcomes of Brentuximab Vedotin Plus AVD versus ABVD in Egyptian Patients with Advanced Classical Hodgkin Lymphoma. Gulf J Oncolog Omar MN, Elsayed ZM, Afify RM, Hussien NM, Abdelkader HA. PMID: 42274064 [PubMed - indexed for MEDLINE]
	The prognostic factors and immune microenvironment of primary plasma cell leukemia: the KMMWP-2204 study. Haematologica Kim M, Jang HC, Ahn JS, Cho H, Lee JJ, Cho HJ, Kim DS, Jung J, Lee JH, Kim K, Byun JM, Yoon DH, Choi YS, Jo JC, Yhim HY, Lee MW, Lim SN, Lee JH, Park SS, Min CK, Jung SH. PMID: 42273949 [PubMed - as supplied by publisher]
	Evolution to complex karyotype disease in mono-allelic TP53-mutated myelodysplastic syndrome/acute myeloid leukemia: a cohort study. Haematologica Fernandes P, Pasca S, Jain T, Levis MJ, Ambinder AJ, Walsh L, Gojo I, Smith DB, Webster J, Ghiaur G, Dalton WB, Prince G, Jones RJ, DeZern AE, Gondek LP, Karantanos T. PMID: 42273942 [PubMed - as supplied by publisher]
	Prognostic Value of Skin Lesion Characteristics in Subcutaneous Panniculitis-Like T-Cell Lymphoma: A Retrospective Cohort Study Assessing the Applicability of T Category of the TNM Classification for Primary Cutaneous Lymphomas Other Than Mycosis Fungoides and SÃ©zary Syndrome. Int J Dermatol Choi ME, Jung JM, Jeon SH, Won CH, Chang SE, Lee MW, Lee WJ. PMID: 42273924 [PubMed - as supplied by publisher]
	Study of Tinospora cordifolia stem and Senna siamea leaf and pods: An in vitro therapeutic approach for leukemia. World J Biol Chem Boro A, Jothi Dheivasikamani A, Prabhu Jeyabal Philomenathan A, Manivannan J, Krishnaswamy S, Palanisamy S, Arumugam VA. PMID: 42273526 [PubMed]
	Synthetic and conventional magnetic resonance imaging for knee assessment in children with leukemia: a comparative study. Quant Imaging Med Surg Jin W, Zhang H, Liao Y, Xiong S, Lei X, Guo X, Yang Z, Zhang R, Liang H, Guo Y, Wu Q, Ye L, Zheng J, Xu R. PMID: 42273147 [PubMed]
	Feasibility and Effectiveness of CALGB 10403 Protocol in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma: A Study at Seyed Al-Shohada Hospital, Isfahan, Iran. Int J Hematol Oncol Stem Cell Res Oghab P, Erfan A, Poorpoone M, Peikar MS. PMID: 42272603 [PubMed]
	Bone Marrow Metastasis of Embryonal Rhabdomyosarcoma in an Adult, Confounding as Acute Leukemia: A Diagnostic Challenge. Int J Hematol Oncol Stem Cell Res Singh S, Porwal J, Kumar K, Singh N, Nath UK. PMID: 42272602 [PubMed]
	Prognostic significance of therapy-induced senescence and SASP dynamics in acute myeloid leukemia: a retrospective cohort study. BMC Cancer Ma B, Zhang L. PMID: 42271269 [PubMed - as supplied by publisher]
	Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report. Leukemia Flerlage JE, Palese M, Birz S, Campo E, de Jong D, Eichenauer DA, Hartmann S, Hoppe RT, Jaffe ES, Natkunam Y, Quintanilla-Martinez L, Martins W, Binkley MS. PMID: 42271037 [PubMed - as supplied by publisher]
	Toxicity and efficacy of four carmustine-substituted conditioning regimens followed by autologous stem cell transplantation in lymphoma: a real-world comparative study. Ann Hematol Pang Y, Du X, Lu W, Shi J. PMID: 42270870 [PubMed - as supplied by publisher]
	Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations. Hematol Oncol Clin North Am Belsky JA, Shoag J, Harker-Murray PD, Kahn JM. PMID: 42270197 [PubMed - in process]
	Updates in Childhood Acute Lymphoblastic Leukemia. Hematol Oncol Clin North Am Zarnegar-Lumley S, McNeer JL. PMID: 42270196 [PubMed - in process]
	Risk of lymphoma associated with biologics and immunosuppressants in inflammatory bowel disease patients: a nationwide nested case-control study. Clin Gastroenterol Hepatol Meyer A, Weill A, Carbonnel F, Dray-Spira R. PMID: 42269996 [PubMed - as supplied by publisher]
	Microcosting of Childhood Hodgkin Lymphoma Treatment Across Resource Levels Using the Adapted Resource and Implementation Application Guidelines in the US. JCO Glob Oncol Aliabadi S, Kumar P, Lucas JT Jr, Norton M, Pauley JL, Sauer HE, Martinez JM, Yasui Y, Bhakta N, Bolous NS. PMID: 42269132 [PubMed - in process]
	Brentuximab Vedotin after AlloSCT for Relapsed/Refractory Hodgkin Lymphoma: GHSG BV-ALLO Phase II Trial. Blood Adv Scheid C, Jablonski J, Kerkhoff A, Stelljes M, Trautmann-Grill K, Bornhäuser M, Tischer J, von Bergwelt-Baildon M, Janson D, Ayuk FA, Kröger N, Holtick U, Richardson T, von Tresckow B, Fuchs M, Borchmann P, Bröckelmann PJ. PMID: 42269084 [PubMed - as supplied by publisher]
	Peripheral blood mRNA expression of IL37, IL1F10, and C17orf99 genes is altered in patients with B-acute lymphoblastic leukemia: a case-control study. Mol Biol Rep Kadhim NT, Abed RM. PMID: 42268443 [PubMed - in process]
	KIT and FLT3-ITD mutations do not predict outcomes in pediatric core-binding factor acute myeloid leukemia: findings from the C-HUANAN-AML-15 multicenter cohort study. Ann Hematol Zheng Y, Yu L, Le S, Li N, Feng X, Li C, Zheng M, Mai H, Jiang H, He X, Wen H, Xu H, Chen C, Yang L. PMID: 42268406 [PubMed - as supplied by publisher]

Articles 1 - 20 / 168198

Page 1 of 8410



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy